# § 520.1618   Orbifloxacin suspension.

(a) *Specifications.* Each milliliter of suspension contains 30 milligrams (mg) orbifloxacin.


(b) *Sponsor.* See No. 000061 in 510.600(c) of this chapter.


(c) *Special considerations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian. Federal law prohibits the extralabel use of this drug in food-producing animals.


(d) *Conditions of use*—(1) *Dogs*—(i) *Amount.* 1.1 to 3.4 mg/lb (2.5 to 7.5 mg/kg) of body weight once daily.


(ii) *Indications for use.* For the treatment of urinary tract infections (cystitis) in dogs caused by susceptible strains of *Staphylococcus pseudintermedius*, *Proteus mirabilis*, *Escherichia coli,* and *Enterococcus faecalis* and skin and soft tissue infections (wounds and abscesses) in dogs caused by susceptible strains of *Staphylococcus pseudintermedius*, *Staphylococcus aureus*, coagulase-positive staphylococci, *Pasteurella multocida*, *Proteus mirabilis*, *Pseudomonas* spp., *Klebsiella pneumoniae*, *E. coli*, *Enterobacter* spp., *Citrobacter* spp., *E. faecalis*, β-hemolytic streptococci (Group G), and *Streptococcus equisimilis.*

(2) *Cats*—(i) *Amount.* 3.4 mg/lb (7.5 mg/kg) of body weight once daily.


(ii) *Indications for use.* For the treatment of skin infections (wounds and abscesses) in cats caused by susceptible strains of *S. aureus*, *E. coli*, and *P. multocida.*


---

[N] [75 FR 26646, May 12, 2010]




